Gymnasterkoreayne F inhibits osteoclast formation by suppressing NFATc1 and DC-STAMP expression

International Immunopharmacology

Volumn 10, Issue 11, 2010, Pages 1440-1447

  Kim, Hyun Ju ^a,b   Hong, JungMin ^a   Jung, Ji Won ^a   Kim, Tae Ho ^a   Kim, Jeong Ah ^d   Kim, Young Ho ^d   Kim, Shin Yoon ^a,c  

^a Kyungpook National University Hospital   (South Korea)

^b Kyungpook National University   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

^d Chungnam National University   (South Korea)

Author keywords

3 integrin; DC STAMP; GK F; NFATc1; Osteoclasts

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; BETA3 INTEGRIN; CATHEPSIN K; GYMNASTERKOREAYNE F; HERBACEOUS AGENT; LIPOPOLYSACCHARIDE; OSTEOCLAST DIFFERENTIATION FACTOR; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSKELETON; GENE EXPRESSION; GYMNASTER KORAIENSIS; MEDICINAL PLANT; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACID PHOSPHATASE; ACTINS; ANIMALS; CATHEPSIN K; CELL DIFFERENTIATION; CELL FUSION; CELLS, CULTURED; GYMNASTICS; INTEGRIN BETA3; ISOENZYMES; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NFATC TRANSCRIPTION FACTORS; OSTEOCLASTS; POLYACETYLENES; RANK LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77958150539     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.08.017     Document Type: Article

References (31)

1. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell l 1998, 93:165-176.
2. Wong B.R., Josien R., Lee S.Y., Sauter B., Li H.L., Steinman R.M., et al. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor. J Exp Med 1997, 186:2075-2080.
3. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998, 95:3597-3602.
4. Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C., Tometsko M.E., Roux E.R., et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997, 390:175-179.
5. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
6. Teitelbaum S.L., Ross F.P. Genetic regulation of osteoclast development and function. Nat Rev Genet 2003, 4:638-649.
7. Teitelbaum S.L. Bone resorption by osteoclasts. Science 2000, 289:1504-1508.
8. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002, 3:889-901.
9. Yagi M., Miyamoto T., Sawatani Y., Iwamoto K., Hosogane N., Fujita N., et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 2005, 202:345-351.
10. Kim K., Lee S.H., Ha Kim J., Choi Y., Kim N. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol Endocrinol 2008, 22:176-185.
11. Faccio R., Novack D.V., Zallone A., Ross F.P., Teitelbaum S.L. Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by beta3 integrin. J Cell Biol 2003, 162:499-509.
12. McHugh K.P., Hodivala-Dilke K., Zheng M.H., Namba N., Lam J., Novack D., et al. Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 2000, 105:433-440.
13. Dat N.T., Cai X.F., Shen Q., Lee I.S., Lee E.J., Park Y.K., et al. Gymnasterkoreayne G, a new inhibitory polyacetylene against NFAT transcription factor from Gymnaster koraiensis. Chem Pharm Bull (Tokyo) l 2005, 53:1194-1196.
14. Jung H.J., Min B.S., Park J.Y., Kim Y.H., Lee H.K., Bae K.H., et al. Gymnasterkoreaynes A-F, cytotoxic polyacetylenes from Gymnaster koraiensis. J Nat Prod 2002, 65:897-901.
15. Park J., Min B., Jung H., Kim Y., Lee H., Bae K. Polyacetylene glycosides from Gymnaster koraiensis. Chem Pharm Bull (Tokyo) l 2002, 50:685-687.
16. Kim H.J., Zhang K., Zhang L., Ross F.P., Teitelbaum S.L., Faccio R. The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo. Proc Natl Acad Sci USA 2009, 106:2325-2330.
17. Takeshita S., Kaji K., Kudo A. Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts. J Bone Miner Res 2000, 15:1477-1488.
18. Kim H.J., Zhao H., Kitaura H., Bhattacharyya S., Brewer J.A., Muglia L.J., et al. Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest 2006, 116:2152-2160.
19. Kobayashi K., Takahashi N., Jimi E., Udagawa N., Takami M., Kotake S., et al. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 2000, 191:275-286.
20. Suda K., Woo J.T., Takami M., Sexton P.M., Nagai K. Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL. J Cell Physiol 2002, 190:101-108.
21. Hirotani H., Tuohy N.A., Woo J.T., Stern P.H., Clipstone N.A. The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem 2004, 279:13984-13992.
22. Asagiri M., Sato K., Usami T., Ochi S., Nishina H., Yoshida H., et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med 2005, 202:1261-1269.
23. Ikeda F., Nishimura R., Matsubara T., Hata K., Reddy S.V., Yoneda T. Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity. J Immunol 2006, 177:2384-2390.
24. Lee S.H., Rho J., Jeong D., Sul J.Y., Kim T., Kim N., et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med 2006, 12:1403-1409.
25. Ishii M., Iwai K., Koike M., Ohshima S., Kudo-Tanaka E., Ishii T., et al. RANKL-induced expression of tetraspanin CD9 in lipid raft membrane microdomain is essential for cell fusion during osteoclastogenesis. J Bone Miner Res 2006, 21:965-976.
26. Mbalaviele G., Chen H., Boyce B.F., Mundy G.R., Yoneda T. The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow. J Clin Invest 1995, 95:2757-2765.
27. Abe E., Mocharla H., Yamate T., Taguchi Y., Manolagas S.C. Meltrin-alpha, a fusion protein involved in multinucleated giant cell and osteoclast formation. Calcif Tissue Int 1999, 64:508-515.
28. Kukita T., Wada N., Kukita A., Kakimoto T., Sandra F., Toh K., et al. RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med 2004, 200:941-946.
29. Zou W., Bar-Shavit Z. Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 2002, 17:1211-1218.
30. Aderem A., Ulevitch R.J. Toll-like receptors in the induction of the innate immune response. Nature 2000, 406:782-787.
31. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001, 1:135-145.